4 Reasons Social Security Is In Trouble - Will You Be, Too?
Worst Things to Buy Before Your Kid Heads Back to School
Monkeys' Behavior Reveals Hidden Threat to Our Wealth
Can Apple Restore the Luster of the iPad?
OXiGENE Closes Enrollment of ZYBRESTAT Phase 2 Ovarian Cancer Trial
OXiGENE Announces $5M Private Placement
Morning Market Movers
Stocks Hitting 52-Week Lows
Solving The R&D Investment Dilemma With Project Funding: Mark Kessel
OXiGENE Announces Patent for Benzosuberenes
OXiGENE Management Discusses Q4 2012 Results - Earnings Call Transcript
3 Stocks Under $5 Making Big Moves
Risk Vs. Reward: 2 Biotech Stocks I'm Considering In The Wake Of Recent Developments
OXiGENE's CEO Discusses Q3 2012 Results - Earnings Call Transcript